RxNorm August 2021 Release

RxNorm August 2021 Release. NLM Tech Bull. 2021 Jul-Aug;(441):b6.

The RxNorm August monthly release became available for download on Monday, August 2, 2021. A name change for the Propoven clinical drug concept was included. See below for more details. 

RXNORM DATA CHANGES

Propoven Concept Now Uses Precise Ingredient Name

Propoven is a sedative allowed under the U.S. Food & Drug Administration Emergency Use Authorization (EUA) during the COVID-19 pandemic. The active ingredient in the Propoven concept name changed from "propofol" to "propofol lipid emulsion" starting with the August 2021 release. The RxNorm Concept Unique Identifier (RXCUI) remained the same.

Here is the original Propoven Semantic Branded Clinical Drug (SBD) Concept Name and RXCUI:

• Original SBD: 100 ML propofol 20 MG/ML Injection [Propoven]
• Original RXCUI: 2370236

Here is the new SBD Concept Name using the precise ingredient "propofol lipid emulsion" and the original RXCUI:

• New SBD: 100 ML propofol lipid emulsion 20 MG/ML Injection [Propoven]
• Original RXCUI:2370236

Below are the generic concept names.

Here is the original generic Semantic Clinical Drug (SCD) name and RXCUI:

• Original SCD: 100 ML propofol 20 MG/ML Injection
• Original RXCUI: 2370234

Here is the new generic SCD name using the precise ingredient "propofol lipid emulsion" and original RXCUI:

• New SCD: 100 ML propofol lipid emulsion 20 MG/ML Injection
• Original RXCUI: 2370234

NOTICE OF UPCOMING DATA CHANGES

As a courtesy to users, this section provides advance notice of possible upcoming RxNorm data changes. More information about each change will be provided or repeated in the future. Please note that planned data changes and timelines may change if issues arise.

• REMINDER: Basis of Strength (BoSS) Attributes Changing Fall 2021 at the Earliest

Several BoSS attributes are planned to change this fall. A specific month is not available, but is likely to occur September 2021 at the earliest. Below are more details. Please plan accordingly.

• BoSS Attributes Moving:
• RXN_BOSS_AI, RXN_BOSS_AM, and RXN_BOSS_FROM attributes will change from being present on an SCDC to an SCD, likewise on an SBDC to an SBD
• Please note that this change will initially affect many but not all relevant concepts. For example, some products, such as medical gases and multi-ingredient products including multivitamins, will be addressed at a later time.
• BoSS Attribute Name Changes:
• RXN_BOSS_AI will be renamed RXN_AI
• RXN_BOSS_AM will be renamed RXN_AM